Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions

Annals of Pharmacotherapy

Volumn 31, Issue 12, 1997, Pages 1465-1470

  Zhang, Yanping ^a   Xu, Quanyun A ^a   Trissel, Lawrence A ^a   Gilbert, Doward L ^a   Martinez, J Frank ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Carboplatin; Cisplatin; Paclitaxel; Stability

Indexed keywords

CARBOPLATIN; CISPLATIN; INFUSION FLUID; PACLITAXEL; POLYOLEFIN;

ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; DRUG DECOMPOSITION; DRUG DETERMINATION; DRUG FORMULATION; DRUG INDICATION; DRUG MIXTURE; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OVARY CANCER; PRIORITY JOURNAL;

EID: 0031469011     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703101204     Document Type: Article

References (13)

1. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A 1980;77:1561-5.
2. Parness J, Horwitz SB. Taxol binds to polymerized tubulin in vitro. J Cell Biol 1981;91:479-87.
3. Package insert. Taxol (paclitaxel). Princeton, NJ: Mead Johnson Oncology, July 1995.
4. McEvoy GK, ed. AHFS drug information '97. Bethesda, MD: American Society of Health-System Pharmacists, 1997:841-5.
5. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
6. Young RC, Perez CA, Hoskins WJ. Cancer of the ovary. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 4th ed. Philadelphia: JB Lippincott Co., 1993:1249-51.
7. Waugh WN, Trissel LA, Stella VJ. Stability, compatibility, and plasticizer extraction of Taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am J Hosp Pharm 1991;48:1520-4.
8. Chin A, Ramakrishnan RR, Yoshimura NN, Jeong EWS, Nii LJ, Di-Meglio LS. Paclitaxel stability and compatibility in polyolefin containers. Ann Pharmacother 1994;28:35-6.
9. Xu Q, Trissel LA, Martinez JF. Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 23, or 32°C. Am J Hosp Pharm 1994;51:3058-60.
10. Trissel LA, Bready BB. Turbidimetric assessment of the compatibility of Taxol with selected other drugs during simulated Y-site injection. Am J Hosp Pharm 1992;49:1716-9.
11. Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of Taxol with 42 other drugs during simulated Y-site injection. Am J Hosp Pharm 1993;50:300-4.
12. Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1993;50:2359-63.
13. Benaji B, Dine T, Luyckx M, Brunet C, Goudaliez F. Stability and compatibility of cisplatin and carboplatin with PVC infusion bags. J Clin Pharm Ther 1994;19:95-100.